Abivax (ABVX) Announces Board Changes

Go back to Abivax (ABVX) Announces Board Changes

Abivax Announces a Change to the Composition of its Board of Directors

December 23, 2024 4:05 PM EST

Abivax Announces a Change to the Composition of its Board of Directors

PARIS, France, December 23, 2024, 10:05 PM CEST Abivax SA (Euronext Paris & Nasdaq: ABVX) (Abivax or the Company), a clinical-stage biotechnology company focused on developing therapeutics that harness the bodys natural regulatory mechanisms to modulate the inflammatory... More